Layoffs and restructuring will prepare Leo Pharma for IPO
On Wednesday, Leo Pharma has let go of 68 employees, and a total of 1,000 positions in the organization will be affected over the next two years. The new operating model is meant to raise earnings prior to an initial public offering, the company says.
by andreas lønstrup, translated by daniel pedersen
The fact that Leo Pharma is currently without a permanent CEO hasn’t changed the company’s great plans for the future.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Headhunter calls outgoing Leo Pharma CEO a "flop"
For subscribers
